Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 4 medicines
Anvisa · 2 medicines
AEMPS · 2 medicines
EMA · 2 medicines
AIFA · 2 medicines
HSA · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
25 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sunlenca | United States | 300MG BASE | tablet | Marketed | Gilead Sciences INC |
| Sunlenca | United States | 463.5MG BASE/1.5ML | solution | Marketed | Gilead Sciences INC |
| Yeztugo | United States | 463.5MG/1.5ML | solution | Marketed | Gilead Sciences INC |
| Yeztugo | United States | 463.5MG BASE/1.5ML | solution | Marketed | Gilead Sciences INC |
| Yeztugo | United States | 300MG BASE | tablet | Marketed | Gilead Sciences INC |
| Sunlenca | European Union | Authorised | Gilead Sciences Ireland Unlimited Company | ||
| Sunlenca 464 MG Solucion Inyectable | Spain | 315,4 mg/ml | solución inyectable | Marketed | Gilead Sciences Ireland Unlimited Company |
| Sunlenca 300 MG Comprimidos Recubiertos con Pelicula | Spain | 306,8 mg | comprimido recubierto con película | Marketed | Gilead Sciences Ireland Unlimited Company |
| Sunlenca | Italy | Compressa rivestita con film | Authorised | Gilead Sciences Ireland Uc | |
| Yeytuo | European Union | Authorised | Gilead Sciences Ireland Unlimited Company | ||
| Sunlenca 300 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| Sunlenca 464 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Gilead Sciences Ireland UC | |
| Sunlenca | Canada | 309 MG / ML | Solution | Marketed | Gilead Sciences Canada INC |
| Sunlenca | Canada | 300 MG | Tablet | Marketed | Gilead Sciences Canada INC |
| Yeytuo | Italy | Compressa rivestita con film | Authorised | Gilead Sciences Ireland Uc | |
| Yeytuo 300 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| Yeytuo 464 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Gilead Sciences Ireland UC | |
| Sunlenca | Brazil | Authorised | Gilead Sciences Farmaceutica do Brasil Ltda | ||
| Sunlenca | Brazil | Authorised | Gilead Sciences Farmaceutica do Brasil Ltda | ||
| Sunlenca film-coated tablet 300mg | Singapore | 300mg | tablet, film coated | Authorised | Gilead Sciences Singapore Pte. LTD. |
| Sunlenca solution for injection 463.5mg/1.5ml | Singapore | 463.5mg/1.5ml | injection, solution | Authorised | Gilead Sciences Singapore Pte. LTD. |
| Yeytuo | Canada | 300 MG | Tablet | Authorised | Gilead Sciences Canada INC |
| Yeytuo | Canada | 309 MG / ML | Solution | Authorised | Gilead Sciences Canada INC |
| Sunlenca | Croatia | Authorised | |||
| Yeytuo | Croatia | Authorised |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada and HSA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
